P. Grosclaude

发表

Construction of an adaptable European transnational ecological deprivation index: the French version

Cyrille Delpierre, Thierry Lang, Guy Launoy, 2012, Journal of Epidemiology & Community Health.

Cancer incidence and mortality in France over the period 1978-2000.

G. Hédelin, G. Launoy, J. Faivre, 2003, Revue d'epidemiologie et de sante publique.

International incidence of childhood cancer, 2001–10: a population-based registry study

Eva Steliarova-Foucher, S Rohrmann, F Levi, 2017, The Lancet. Oncology.

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

M. Coleman, F. Berrino, T. Hakulinen, 2003, International journal of cancer.

Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas.

R. Capocaccia, P. Grosclaude, A. Micheli, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival of solid cancer patients in France, 1989–2013: a population-based study

N. Voirin, A. Guizard, B. Trétarre, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Cancers : pronostics à long terme

S. Culine, B. Asselain, P. Grosclaude, 2006 .

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.

Laurence Leenhardt, P. Grosclaude, L. Leenhardt, 2004, Thyroid : official journal of the American Thyroid Association.

A novel approach for medical research on lymphomas

M. Lapeyre-Mestre, C. Conte, F. Despas, 2018, Medicine.

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Melissa Matz, F Berrino, B Rachet, 2018, The Lancet.

Evaluation of the management of rectal cancers before and after the consensus conference in France

J. Faivre, P. Arveux, J. Daurès, 2004, European journal of gastroenterology & hepatology.

The impact of physician's characteristics on decision-making inhead and neck oncology: Results of a national survey.

S. Lamy, P. Grosclaude, S. Vergez, 2022, Oral oncology.

Trends in incidence of digestive cancers in France

G. Launoy, C. Lepage, J. Faivre, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000.

G. Launoy, J. Faivre, B. Trétarre, 2007, Gastroenterologie clinique et biologique.

Unbiased estimates of long‐term net survival of solid cancers in France

G. Launoy, V. Jooste, P. Arveux, 2013, International journal of cancer.

Trends in Kaposi's Sarcoma Survival Disparities in the United States: 1980 through 2004

I. Kawachi, C. Delpierre, T. Lang, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN.

V. Rondeau, G. Launoy, P. Arveux, 2019, Environment international.

Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort

G. Launoy, P. Arveux, X. Troussard, 2019, Cancer Causes & Control.

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).

A. Villers, E. Heijnsdijk, J. Hugosson, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Childhood adversity as a risk for cancer: findings from the 1958 British birth cohort study

C. Delpierre, T. Lang, P. Grosclaude, 2013, BMC Public Health.

Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis

C. Delpierre, M. Carayol, P. Grosclaude, 2010, Cancer Causes & Control.

[Epidemiology of thyroid carcinoma over the world].

P. Grosclaude, L. Leenhardt, 2011, Annales d'endocrinologie.

Conditional relative survival of cancer patients and conditional probability of death

G. Hédelin, G. Launoy, V. Jooste, 2009, Cancer.

Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.

V. Bouvier, J. Faivre, M. Sant, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Regional variations in management of rectal cancer in France.

G. Launoy, J. Faivre, B. Trétarre, 2004, Gastroenterologie clinique et biologique.

Prevalence of cancer in the elderly: discrepancies between self-reported and registry data.

F. Berthier, P. Grosclaude, F. Cayla, 1997, British Journal of Cancer.

Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)

C. Leux, P. Grosclaude, P. Lombrail, 2016, International journal of cancer.

Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer

P. Grosclaude, J. Delord, L. Gimenez, 2020, BMC Cancer.

Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries

A. Guizard, B. Trétarre, P. Grosclaude, 2018, BMC Cancer.

National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct?

P. Grosclaude, L. Remontet, M. Colonna, 2013, Cancer epidemiology.

A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000).

B. Franc, A. Guizard, P. Grosclaude, 2007, European journal of cancer.

Long-term trends in incidence and survival of penile cancer in France.

G. Defossez, B. Trétarre, P. Grosclaude, 2017, Cancer epidemiology.

Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database

P. Grosclaude, L. Remontet, M. Colonna, 2007, European Journal of Epidemiology.

Incidence of gastrointestinal cancers in France.

G. Launoy, J. Faivre, P. Arveux, 2004, Gastroenterologie clinique et biologique.

Participation Behavior of Bladder Cancer Survivors in a Medical Follow-Up Surveyon Quality of Life in France

P. Grosclaude, T. Matsuda, H. Marche, 2003, European Journal of Epidemiology.

[Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].

C. Abbou, A. Villers, P. Grosclaude, 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.

G. Launoy, A. Guizard, B. Trétarre, 2008, European journal of cancer.

Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996

P. Arveux, P. Grosclaude, F. Ménégoz, 2002, International journal of cancer.

Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.

A. Guizard, P. Grosclaude, L. Remontet, 2010, Annales d'endocrinologie.

ARTICLE Incidence of gastrointestinal cancers in France

G. Launoy, J. Faivre, P. Arveux, 2004 .

Socioeconomic status and site-specific cancer incidence, a Bayesian approach in a French Cancer Registries Network study

G. Launoy, O. Dejardin, P. Grosclaude, 2016, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

nds in Kaposi ' s Sarcoma Survival Disparities in the B & P ted States : 1980 through 2004

I. Kawachi, C. Delpierre, T. Lang, 2010 .

Projection de l’incidence et de la mortalité par cancer urologique en France en 2012

J. Patard, L. Salomon, A. Villers, 2013 .

Assessment of the ecological bias of seven aggregate social deprivation indices

O. Lantieri, G. Launoy, C. Delpierre, 2017, BMC Public Health.

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

G. Launoy, J. Faivre, P. Arveux, 2007, European journal of cancer.

Projection de l’incidence et de la mortalité par cancer urologique en France en 2010

J. Patard, L. Salomon, X. Rébillard, 2010 .

Are there regional differences in the management of colon cancer in France?

G. Launoy, J. Faivre, B. Trétarre, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

A population-based study on radical prostatectomy in France

A. Villers, J. Macé-Lesec’h, P. Grosclaude, 2001, Prostate Cancer and Prostatic Diseases.

Evaluation of long-term living conditions in patients treated for localised prostate cancer.

F. Joly, N. Heutte, A. Guizard, 2020, European journal of cancer care.

Lymph node harvest reporting in patients with carcinoma of the large bowel

G. Launoy, J. Faivre, P. Arveux, 1998, Cancer.

Non-medical exposure to radioiodines and thyroid cancer

E. Hindié, A. Aurengo, P. Grosclaude, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997).

P. Arveux, J. Estève, A. Guizard, 2002, European journal of cancer.

[Compensable occupational disease and cancer: how to improve the recognition rate? "Cursus Laboris" Project in Midi-Pyrenees: feasibility study].

S. Oustric, P. Grosclaude, J. Delord, 2012, Bulletin du cancer.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

A. Gavin, H. Comber, M. Rugge, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].

A. Villers, P. Grosclaude, A. Ruffion, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

P. Arveux, A. Guizard, B. Trétarre, 2015, Gynecologic oncology.

Le cancer de la prostate, le point sur le dépistage

P. Grosclaude, 2008 .

[Current management and prognosis of intrahepatic cholangiocarcinoma in France].

G. Launoy, J. Faivre, B. Trétarre, 2009, Gastroenterologie clinique et biologique.

[Current management and prognosis of intrahepatic cholangiocarcinoma in France].

G. Launoy, J. Faivre, B. Trétarre, 2009, Gastroentérologie Clinique et Biologique.

A population-based study on management of prostate cancer in four regions of France

A. Villers, L. Molinier, J. Macé-Lesec’h, 2001, Prostate Cancer and Prostatic Diseases.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

N. Girard, A. Gavin, H. Comber, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Estimate of regional prevalence of colorectal cancer in France].

G. Launoy, J. Faivre, P. Arveux, 2002, Revue d'epidemiologie et de sante publique.

Disentangling the influence of living place and socioeconomic position on health services use among diabetes patients: A population-based study

C. Delpierre, S. Lamy, P. Grosclaude, 2017, PloS one.

Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites

V. Jooste, P. Grosclaude, A. Bouvier, 2022, Cancer.

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

F Berrino, P Roazzi, F. Berrino, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: A study of five common cancers

P. Grosclaude, L. Remontet, M. Colonna, 2010, International journal of cancer.

[Descriptive and prognostic value of health status perception by a group of patients with chronic respiratory insufficiency using respirators].

D. Bucquet, P. Grosclaude, H. Bocquet, 1989, Revue des maladies respiratoires.

Erratum: Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe (International Journal of Cancer (2003) 106 (416-42))

M. Coleman, J. Coebergh, F. Berrino, 2003 .

Cancer Risk in Women Exposed to Diethylstilbestrol in Utero.

M. Espié, B. Asselain, P. Grosclaude, 2015, Therapie.

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice

C. Lepage, V. Jooste, V. Quipourt, 2022, Cancers.

[Reporting of resected colonic carcinomas. Assessment of practices in 8 French counties in 1995].

G. Launoy, J. Faivre, P. Arveux, 1999, Gastroenterologie clinique et biologique.

Les cancers du larynx en France : éléments d’épidémiologie descriptive et estimation de l’incidence nationale

G. Launoy, B. Trétarre, P. Grosclaude, 2004 .

[Larynx cancer in France: descriptive epidemiology and incidence estimation].

G. Launoy, A. Guizard, B. Trétarre, 2004, Bulletin du cancer.

[Female genital and breast cancers in France: geographic distribution and estimation of incidence].

P. Arveux, J. Daurès, P. Grosclaude, 1997, Bulletin du cancer.

[Digestive cancers in France. Geographic distribution and estimation of national incidence].

G. Launoy, J. Faivre, P. Arveux, 1997, Gastroenterologie clinique et biologique.

[Digestive cancers in France. Comparison of the incidence in 7 departments and estimation of incidence in the entire country of France].

S. Schraub, G. Launoy, J. Faivre, 1992, Gastroenterologie clinique et biologique.

Identifying multiple myeloma patients using data from the French health insurance databases

M. Lapeyre-Mestre, C. Conte, F. Despas, 2017, Medicine.

Treatment time interval in breast cancer: A population‐based study on the impact of type and number of cancer centres attended

C. Delpierre, S. Lamy, P. Grosclaude, 2022, European journal of cancer care.

Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM)

A. Dumas, P. Grosclaude, F. de Vathaire, 2022, PloS one.

[Use of medical and administrative databases to measure social health inequalities].

P. Grosclaude, F. Cayla, M. Tanguy, 2015, Sante publique.

Experimental system of care coordination for the home return of patients with metastatic cancer: a survey of general practitioners

C. Delpierre, P. Grosclaude, L. Gimenez, 2022, BMC Primary Care.

[Epidemiology of prostate cancer].

P. Grosclaude, M. Roumagnac, 1992, Annales d'Urologie.

Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study

E. Steliarova-Foucher, J. Coebergh, F. Bray, 2018, The Lancet. Oncology.

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.

A. Gavin, H. Comber, M. Rugge, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adverse childhood experiences and premature all-cause mortality

C. Delpierre, T. Lang, P. Grosclaude, 2013, European Journal of Epidemiology.

[Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].

A. Villers, P. Arveux, P. Grosclaude, 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Trends in the risk of second primary cancer among bladder cancer survivors: a population‐based cohort of 10 047 patients

V. Bouvier, X. Troussard, A. Guizard, 2016, BJU international.

The embodiment of adverse childhood experiences and cancer development: potential biological mechanisms and pathways across the life course

C. Delpierre, T. Lang, P. Grosclaude, 2013, International Journal of Public Health.

Methodological considerations in cost of prostate cancer studies: a systematic review.

C. Combescure, J. Daurès, L. Molinier, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[Prostate cancer incidence and mortality trends in France from 1980 to 2011].

P. Grosclaude, L. Remontet, M. Velten, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000–2008

V. Bouvier, X. Troussard, A. Guizard, 2013, Pediatric hematology and oncology.

The histology of brain tumours for 67,331 children and 671,085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).

R. Malekzadeh, M. Coleman, S. Rosso, 2021, Neuro-oncology.

Cancer incidence and mortality in France over the period 1980-2005.

M Colonna, N. Le Stang, G. Hédelin, 2008, Revue d'epidemiologie et de sante publique.

Determinants of quality of life of bladder cancer survivors five years after treatment in France

P. Grosclaude, C. Exbrayat, T. Matsuda, 2003, International journal of urology : official journal of the Japanese Urological Association.

Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.

P. Grosclaude, M. Mercier, J. Mace-Lesech, 1995, British Journal of Cancer.

Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study

J. Coebergh, F. Berrino, M. Federico, 2004, British Journal of Cancer.

Merkel cell carcinoma in France: a registries‐based, comprehensive epidemiological survey

A. Guizard, B. Trétarre, P. Grosclaude, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

M. Federico, E. Paci, A. Bordoni, 2013, Breast.

Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.

V. Bouvier, X. Troussard, A. Guizard, 2016, Preventive medicine.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

A. Gavin, H. Comber, M. Rugge, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, International journal of cancer.

Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France.

A. Guizard, P. Grosclaude, M. Colonna, 2015, Cancer epidemiology.

Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.

F. Berthier, N. Daly-Schveitzer, P. Grosclaude, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Total and partial cancer prevalence in the adult French population in 2008

P. Grosclaude, M. Colonna, N. Bossard, 2015, BMC Cancer.

Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing

G. Defossez, V. Bouvier, A. Guizard, 2021, BMC Cancer.

[Incidence and mortality of urological cancers in 2012 in France].

J. Patard, L. Salomon, A. Villers, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study.

B. Bui, J. Coindre, S. Mathoulin-Pélissier, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods

Coraline Danieli, P. Grosclaude, A. Bouvier, 2013, International journal of cancer.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study.

P. Grosclaude, C. Vaysse, C. Bernard‐Marty, 2019, Breast.

Cancer incidence and mortality in France in 1975-95.

J. Ferlay, J. Faivre, P. Arveux, 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018

G. Defossez, A. Guizard, P. Grosclaude, 2023, Journal of clinical medicine.

Outcomes of comprehensive geriatric assessment and surgical management in head and neck cancers of the elderly: an observational study

P. Grosclaude, S. Vergez, A. Dupret-Bories, 2022, European Archives of Oto-Rhino-Laryngology.

Diagnosed with Cancer in Mainland France 1989-2018 Summary of Results: Solid Tumours and Haematological Malignancies

G. Defossez, B. Trétarre, P. Grosclaude, 2021 .

Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departments.

S. Mathoulin-Pélissier, P. Grosclaude, B. Amadéo, 2020, Clinics And Research in Hepatology and Gastroenterology.

Trends in incidence of small bowel cancer according to histology: a population-based study

G. Defossez, V. Bouvier, G. Launoy, 2019, Journal of Gastroenterology.

Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

M. Coleman, S. Rosso, H. Comber, 2017, The Lancet. Haematology.

Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

V. Zadnik, C. Castro, G. Tagliabue, 2020, Breast Cancer Research and Treatment.

Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial

C. Delpierre, M. Durand, R. Touzani, 2021, BMC Public Health.

Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example

C. Delpierre, S. Lamy, P. Grosclaude, 2019, BMC Public Health.

The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study

C. Delpierre, G. Laurent, C. Récher, 2016, BMC Health Services Research.

Primitive liver cancers: epidemiology and geographical study in France

G. Launoy, J. Faivre, A. Guizard, 2009, European journal of gastroenterology & hepatology.

Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study.

F. Joly, N. Heutte, A. Guizard, 2016, European journal of cancer.

Breast cancer survival in the US and Europe: A CONCORD high‐resolution study

M. Coleman, F. Berrino, J. Fulton, 2013, International journal of cancer.

Breast carcinoma survival in Europe and the United States

M. Coleman, J. Coebergh, F. Berrino, 2004, Cancer.

Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk

P. Grosclaude, B. Malavaud, M. Soulié, 2017, World Journal of Urology.

[Resolution of megaesophagus after treatment of concurrent hypothyroidism in a dog].

P. Grosclaude, W. Armbrust, E. Huber, 2001, Schweizer Archiv für Tierheilkunde.

[Incidence and mortality of prostate cancer in France: trends between 1978 and 2000].

P. Grosclaude, L. Remontet, É. Bauvin, 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Reply to Ivica Ratosa et al. Comment on: “Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study”

P. Grosclaude, L. Daubisse-Marliac, E. Pons-Tostivint, 2020, Breast.

Cancer incidence estimation at a district level without a national registry: a validation study for 24 cancer sites using French health insurance and registry data.

A. Weill, P. Grosclaude, L. Remontet, 2013, Cancer epidemiology.

Reply to “Survivorship experience: More than premature mortality from cancer”

V. Jooste, P. Grosclaude, A. Bouvier, 2022, Cancer.

Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. an analysis of differential trends in incidence and mortality in France, Italy and Spain.

S. Parodi, M. Vercelli, P. Grosclaude, 2003, European journal of cancer.

Primary care physicians and oncologists are partners in cancer announcement

C. Delpierre, E. Escourrou, S. Oustric, 2016, Supportive Care in Cancer.

The stake of informing patients of the risk of hypofertility after chemotherapy for breast cancer

F. Dalenc, S. Lamy, P. Grosclaude, 2023, Frontiers in Public Health.

Access to information and oncofertility consultation for young women with breast cancer: a population-based study

F. Dalenc, S. Lamy, P. Grosclaude, 2023, Scientific Reports.

The cancer survival gap between elderly and middle-aged patients in Europe is widening.

H. Brenner, M. Janssen-Heijnen, M. Vercelli, 2009, European journal of cancer.

[Ovarian cancer: incidence and mortality in France].

P. Arveux, J. Daurès, A. Guizard, 2005, Journal de gynecologie, obstetrique et biologie de la reproduction.

How does comorbidity affect colon cancer patients' care trajectory? Results from the French EvaCCoR cohort study.

C. Delpierre, R. Guimbaud, S. Lamy, 2020, Clinics and research in hepatology and gastroenterology.

Socioeconomic and geographic determinants of survival of patients with digestive cancer in France

G. de Pouvourville, S. Boutreux, G. Launoy, 2006, British Journal of Cancer.

Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983-2002.

P. Arveux, P. Grosclaude, M. Colonna, 2008, Breast.

Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region

M. Coleman, J. Schillinger, P. Grosclaude, 1999, Archives of disease in childhood.

What is the most appropriate period to define synchronous cancers?

V. Bouvier, X. Troussard, A. Guizard, 2021, Cancer epidemiology.

Survival of women with breast cancer in France: variation with age, stage and treatment

G. Hédelin, P. Arveux, B. Trétarre, 2001, Breast Cancer Research and Treatment.

Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study.

M. Federico, K. Holli, M. Vercelli, 2010, European journal of cancer.

Subregional variations of dietary consumption and incidences of cancers in southern France.

B. Trétarre, P. Grosclaude, M. Gerber, 2002, IARC scientific publications.

The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study

P. Arveux, F. Bonnetain, P. Grosclaude, 2008, British Journal of Cancer.

Predictive value of life events, psychosocial factors and self-rated health on disability in an elderly rural French population.

P. Grosclaude, H. Bocquet, J. Albarède, 1988, Social science & medicine.

Cancer survival among adolescents in France.

B. Trétarre, P. Grosclaude, L. Brugières, 2006, European journal of cancer.

[Estimating the incidence of colorectal cancer in France from a hospital discharge database, 1999-2003].

P. Grosclaude, L. Remontet, M. Colonna, 2009, Revue d'epidemiologie et de sante publique.

Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

S. Rosso, V. Zadnik, H. Brenner, 2019, Archives of Gynecology and Obstetrics.

Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study.

C. Delpierre, R. Guimbaud, S. Lamy, 2019, Clinics and research in hepatology and gastroenterology.

A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.

G. Launoy, J. Faivre, B. Trétarre, 2010, Gastroenterologie clinique et biologique.

Cancer registry data based estimation of regional cancer incidence: application to breast and colorectal cancer in French administrative regions.

M Colonna, P Schaffer, G. Launoy, 1999, Journal of epidemiology and community health.

Enabling the transferability of complex interventions: exploring the combination of an intervention’s key functions and implementation

Mélanie Villeval, Elsa Bidault, Jeannie Shoveller, 2016, International Journal of Public Health.

National cancer prevalence estimation in France

G. Hédelin, G. Launoy, J. Faivre, 2000, International journal of cancer.

Estimation of colorectal cancer prevalence in France.

G. Launoy, J. Faivre, P. Arveux, 2001, European journal of cancer.

Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study

P. Grosclaude, N. Larranaga, L. Roche, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.

Laurent Remontet, Jean Iwaz, Marc Colonna, 2011, Cancer epidemiology.

[Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].

P. Grosclaude, L. Remontet, M. Colonna, 2008, Revue d'epidemiologie et de sante publique.

Impact of comorbidity in DBLCL: direct and indirect effects on survival through unplanned chemotherapy dose reduction

C. Delpierre, G. Laurent, S. Lamy, 2019, Journal of internal medicine.

Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries.

P. Grosclaude, M. Colonna, L. Daubisse-Marliac, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

l ’ incidence du cancer colorectal en France à partir des données hospitalières , 1999 – 2003 Estimating infra-national incidence of colorectal cancer in France from hospital discharge database , 1999 – 2003

P. Grosclaude, L. Remontet, M. Colonna, 2009 .

[Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)].

B. Trétarre, P. Grosclaude, M. Colonna, 2006, Revue d'epidemiologie et de sante publique.

Dietary and socio-economic factors associated with overweight and obesity in a southern French population

P. Grosclaude, M. Gerber, J. Scali, 2004, Public Health Nutrition.

Life expectancy estimates as a key factor in over-treatment: the case of prostate cancer.

Marc Colonna, Michelle Kelly-Irving, Cyrille Delpierre, 2013, Cancer epidemiology.

Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries

A. Guizard, B. Trétarre, P. Grosclaude, 2018, BMC Cancer.

Prostate cancer treatment in Europe at the end of 1990s

J. Coebergh, F. Berrino, G. Gatta, 2009, Acta oncologica.

Descriptive epidemiology of cerebral gliomas in France

P Schaffer, J. Daurès, J. Delattre, 1997, Cancer.

Inventory of tools for care coordination between general practice and hospital system for patients suffering from cancer in active phase of treatment: A scoping review.

C. Delpierre, P. Grosclaude, L. Gimenez, 2020, European journal of cancer care.

Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

J. Daurès, L. Molinier, X. Rébillard, 2011, The European Journal of Health Economics.

Treatment and prognosis of hepatocellular carcinoma: A population based study in France

G. Launoy, J. Faivre, B. Trétarre, 2008, Journal of surgical oncology.

Cancer incidence among adolescents in France

B. Trétarre, P. Grosclaude, L. Brugières, 2004, Pediatric blood & cancer.

[Prostate cancer management and factors associated with radical prostatectomy in France in 2001].

A. Guizard, X. Rébillard, B. Trétarre, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Medical and non-medical determinants of prostate cancer management: a population-based study.

A. Villers, J. Macé-Lesec’h, P. Grosclaude, 2003, European journal of cancer.

[Cancer of the prostate in France: results of the survey CCAFU-FRANCIM].

A. Villers, L. Molinier, J. Macé-Lesec’h, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Time trends and short term projections of cancer prevalence in France.

V. Jooste, P. Grosclaude, M. Colonna, 2018, Cancer epidemiology.

[Disabilities during aging: descriptive approach and risk factors. 4-year longitudinal study of an aged rural population].

P. Grosclaude, H. Bocquet, J. Albarède, 1989, Revue d'epidemiologie et de sante publique.

Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France

C. Delpierre, S. Lamy, P. Grosclaude, 2022, BMJ Open.

Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates.

G. Defossez, P. Grosclaude, L. Remontet, 2020, International journal of epidemiology.

[Contribution of cancer registries to the evaluation of cancer treatment: on the example of rectal cancer].

G. Launoy, J. Faivre, J. Maurel, 1996, Annales de Chirurgie.

How to produce sound predictions of incidence at a district level using either health care or mortality data in the absence of a national registry: the example of cancer in France.

P. Grosclaude, L. Remontet, M. Colonna, 2020, International journal of epidemiology.

Guideline sheets on the side effects of anticancer drugs are useful for general practitioners

F. Bertucci, M. Lapeyre-Mestre, S. Oustric, 2015, Supportive Care in Cancer.

Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

P. Grosclaude, M. Carulla, J. Galceran, 2022, International journal of environmental research and public health.

Cancer de la prostate

L. Salomon, A. Villers, P. Maingon, 2007 .

[Demography of oncologic practitioners working in France. Projection elements for the next 30 years].

P. Grosclaude, J. Delord, R. Bugat, 2004, Bulletin du Cancer.

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].

A. Villers, G. Salama, X. Rébillard, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Population-Based Cancer Registries: A Data Stream to Help Build an Evidence-Based Cancer Policy for Europe and for European Countries

V. Zadnik, P. Grosclaude, 2021 .

Valuing damage to historic buildings using a contingent market: a case study of road traffic externalities

N. Soguel, P. Grosclaude, 1994 .

Influence of social deprivation on benzodiazepines dispensing among children and adolescents: a large cross-sectional population-based study in France.

C. Delpierre, P. Grosclaude, D. Driot, 2023, La Presse Médicale Open.

Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France.

A. Guizard, P. Grosclaude, M. Colonna, 2015, Cancer Epidemiology.

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

N. Girard, A. Gavin, H. Comber, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000–2008

V. Bouvier, X. Troussard, A. Guizard, 2013, Pediatric hematology and oncology.

Link between the referring physician and breast and cervical cancers screening: a cross-sectional study in France

C. Delpierre, P. Grosclaude, Vladimir Druel, 2023, BMC Primary Care.

[Alcohol consumption by young adults from three cities in Southern France].

P. Grosclaude, M. Gerber, J. Scali, 2002, Revue d'epidemiologie et de sante publique.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

H. Comber, J. Rashbass, I. Vergote, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000.

G. Launoy, J. Faivre, B. Trétarre, 2007, Gastroenterologie clinique et biologique.

[Regional state of play of the access to oncofertility consultation for young women with breast cancer].

F. Dalenc, J. Parinaud, P. Grosclaude, 2019, Gynecologie, obstetrique, fertilite & senologie.

Treatment and prognosis of hepatocellular carcinoma: A population based study in France

G. Launoy, J. Faivre, B. Trétarre, 2008, Journal of Surgical Oncology.

Trends in Kaposi's Sarcoma Survival Disparities in the United States: 1980 through 2004

I. Kawachi, C. Delpierre, T. Lang, 2010, Cancer Epidemiology, Biomarkers & Prevention.